Skip to content

Using Facebook to Support Opioid Recovery Among American Indian Women

Facebook Intervention for Preventing Opioid Relapse Among American Indian Women: Wiidookaage'Win Pilot Preparatory Study (Aim 2)

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05995886
Enrollment
60
Registered
2023-08-16
Start date
2023-10-16
Completion date
2026-10-31
Last updated
2026-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Opioid Use Disorder

Keywords

American Indian or Alaska Native, Internet-based Intervention, Community-based Participatory Research, Minnesota, Ethnic and Racial Minorities, Women's Health

Brief summary

The purpose of this study is to find out whether a Facebook group will help Native women in recovery from opioid use.

Interventions

An online social media group program that incorporates social support, mindfulness-based, and cultural practices that may support OUD recovery.

Sponsors

Mayo Clinic
Lead SponsorOTHER
National Institute on Drug Abuse (NIDA)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. AIAN person based on self-reported race/ethnicity 2. Gender identity as a woman 3. At least 18 years of age with no upper age limit 4. Resides in Minnesota 5. Meets criteria for OUD based on the DSM-5 Checklist (American Psychiatric Association, 2013) 6. Self-reports at least one month of abstinence from opioid use based on TLFB interview and negative urine opiate screen 7. Current use of MOUD 8. Is comfortable speaking and reading English 9. Has an existing Facebook account or willing to set one up 10. Is willing and able to participate in the Facebook intervention for 3 months 11. Has access to broadband internet on a mobile phone/computer/tablet at any location 12. Is willing and able to travel to a community clinic in Minneapolis, Minnesota for the UDS or is willing to and able to complete a virtual Zoom UDS visit. 13. Provides written informed consent

Exclusion criteria

1. Self-reports current suicidality based on the Concise Heath Risk Tracking scale 2. Participated in prior study phases (Aim 1 formative work) of NIDA CTN-0123

Design outcomes

Primary

MeasureTime frameDescription
Feasibility of Facebook Intervention3 monthsThe study team will measure the feasibility from the combined reports of recruitment, study retention, level of Facebook intervention uptake/engagement, and treatment satisfaction.

Secondary

MeasureTime frameDescription
Timeline Follow-back Interview and UDS to measure Opioid Abstinence6 monthsThe study team will explore the preliminary differential impact of the intervention compared with the control condition on opioid abstinence and MOUD continuation. Opioid and other substance use will be assessed through monthly Timeline Follow-Back (TLFB) interviews (Sobell \& Sobell, 1992; Wray et al., 2016). At 1, 3, and 6-months, the study team will obtain a UDS that will be used along with the TLFB interviews to measure opioid abstinence.
Reporting MOUD continuation6 monthsThe study team will summarize MOUD continuation as the proportion of participants reporting current use at 6-month follow-up.

Countries

United States

Contacts

CONTACTAshley Brown
wiidookaagewin@mayo.edu1-833-880-2600
PRINCIPAL_INVESTIGATORChristi A Patten, PhD

Mayo Clinic

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 5, 2026